Join

Compare · IMCC vs RGC

IMCC vs RGC

Side-by-side comparison of IM Cannabis Corp. (IMCC) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both IMCC and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • RGC is the larger of the two at $9.88B, about 5801.1x IMCC ($1.7M).
  • Over the past year, IMCC is down 88.3% and RGC is up 34.4% - RGC leads by 122.7 points.
  • RGC has been more active in the news (6 items in the past 4 weeks vs 2 for IMCC).
  • IMCC has more recent analyst coverage (3 ratings vs 0 for RGC).
PerformanceIMCC-88.34%RGC+34.37%
2025-06-09+0.00%2026-06-05
MetricIMCCRGC
Company
IM Cannabis Corp.
Regencell Bioscience Holdings Limited
Price
$0.28-3.08%
$21.58+7.42%
Market cap
$1.7M
$9.88B
1M return
+6.42%
-32.29%
1Y return
-88.34%
+34.37%
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
2
6
Recent ratings
3
0
IMCC

IM Cannabis Corp.

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.